UVE trades 5.2% above Wall Street's consensus target of $40.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UVE achieves its forward estimates and maintains a stable P/E multiple of 9.1x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Universal Insurance Holdings, Inc. (UVE) has a Wall Street consensus price target of $40.00, based on estimates from 4 covering analysts. With the stock currently trading at $42.20, this represents a potential downside of -5.2%. The company has a market capitalization of $1.18B.
Analyst price targets range from a low of $40.00 to a high of $40.00, representing a 0% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, UVE trades at a trailing P/E of 6.7x and forward P/E of 9.1x. The forward PEG ratio of 0.15 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -32.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $48.81, with bear and bull scenarios of $30.75 and $64.31 respectively. Model confidence stands at 49/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HCIHCI Group, Inc. | $2.3B | $180.41 | $126.50 | -29.9% | Buy | 10.4x | 14 |
HRTGHeritage Insurance Holdings, Inc. | $826M | $27.20 | $36.00 | +32.4% | Buy | 6.3x | 9 |
ALLThe Allstate Corporation | $64.7B | $251.46 | $250.00 | -0.6% | Hold | 8.3x | 44 |
TRVThe Travelers Companies, Inc. | $73.1B | $343.73 | $310.40 | -9.7% | Hold | 12.2x | 43 |
CBChubb Limited | $139.4B | $359.30 | $346.75 | -3.5% | Buy | 13.3x | 43 |
PGRThe Progressive Corporation | $137.0B | $234.40 | $228.25 | -2.6% | Hold | 13.6x | 41 |
CINFCincinnati Financial Corporation | $29.4B | $189.06 | $182.50 | -3.5% | Buy | 21.8x | 17 |
KMPRKemper Corporation | $1.7B | $29.50 | $36.00 | +22.0% | Buy | 14.3x | 12 |
RNRRenaissanceRe Holdings Ltd. | $13.8B | $323.69 | $310.75 | -4.0% | Hold | 7.9x | 28 |
AXSAXIS Capital Holdings Limited | $8.4B | $114.53 | $123.67 | +8.0% | Buy | 8.6x | 29 |
Quick answers to the most common questions about buying UVE stock.
Wall Street's consensus price target for UVE is $40, -5.2% from its current price of $42.2. The below-market target from 4 analysts suggests limited near-term appreciation.
UVE has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $40 implies -5.2% downside from current levels.
With a forward P/E of 9.1243x, UVE trades at a relatively low valuation. The consensus target of $40 implies -5.2% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $40 for UVE, while the most conservative target is $40. The consensus of $40 represents the median expectation. Our quantitative valuation model projects a bull case target of $64 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UVE is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UVE stock forecast based on 4 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $40 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $49, with bear/bull scenarios of $31/$64.
Our quantitative valuation model calculates UVE's fair value at $49 (base case), with a bear case of $31 and bull case of $64. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 49/100.
UVE trades at a forward P/E ratio of 9.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 6.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on UVE, with 1 Sell ratings and a price target of $40 (-5.2% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UVE analyst price targets range from $40 to $40, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground. Our model's $31-$64 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.